Completed
ACT-RCT-C 01: a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)
- Status
- Completed
- Registry ID
- NCT00672607
- Type
- Interventional (tests a treatment)
- Phase
- Phase 2
- Conditions
- Premenstrual Syndrome
- What is tested
- extracts of Vitex agnus castus tablets (drug); Placebo (drug)
- Sponsor
- Schwabe-Wenex International Ltd
- Where
- China
- Participants
- 217
- Start
- 2005-02
- Completion
- 2007-01
- Last update
- 2009-10-01
About the study
To compare the efficacy and safety of Agnucaston tablets with placebo for the treatment of Premenstrual Syndrome (PMS) and assess if Agnucaston tablets are superior to placebo on efficacy or not.
Summary from ClinicalTrials.gov.